Tempus AI (NASDAQ:TEM) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group started coverage on shares of Tempus AI (NASDAQ:TEM) in a report published on Monday, Marketbeat.com reports. The firm issued a neutral rating and a $75.00 price objective on the stock.

A number of other research analysts also recently weighed in on TEM. Weiss Ratings upgraded Tempus AI from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, September 11th. Raymond James Financial set a $80.00 price objective on Tempus AI in a research note on Wednesday, September 2nd. Wall Street Zen upgraded Tempus AI from a “sell” rating to a “hold” rating in a research report on Saturday, July 25th. Stifel Nicolaus lowered their target price on Tempus AI from $60.00 to $50.00 and set a “hold” rating on the stock in a research note on Monday, August 3rd. Finally, BTIG Research upped their target price on Tempus AI from $70.00 to $80.00 and gave the company a “buy” rating in a report on Thursday, August 20th. Eleven research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Tempus AI has an average rating of “Hold” and an average target price of $69.63.

Tempus AI Trading Down 0.8%

Tempus AI stock opened at $76.59 on Monday. Tempus AI has a 52 week low of $40.77 and a 52 week high of $104.32. The company has a debt-to-equity ratio of 3.06, a quick ratio of 3.16 and a current ratio of 3.30. The firm has a market capitalization of $13.82 billion, a price-to-earnings ratio of -53.19 and a beta of 3.72. The company has a 50 day moving average price of $58.39 and a 200 day moving average price of $53.43.

Tempus AI (NASDAQ:TEM) last announced its earnings results on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.10. The company had revenue of $382.49 million for the quarter, compared to the consensus estimate of $379.69 million. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The company’s revenue was up 21.6% on a year-over-year basis. During the same period in the previous year, the business earned ($0.22) EPS. Research analysts forecast that Tempus AI will post -1.38 EPS for the current year.

Insider Activity

In related news, CEO Eric Lefkofsky sold 200,000 shares of Tempus AI stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $80.57, for a total transaction of $16,114,000.00. Following the completion of the sale, the chief executive officer owned 809,631 shares of the company’s stock, valued at approximately $65,231,969.67. This trade represents a 19.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Ryan Bartolucci sold 7,062 shares of the business’s stock in a transaction dated Thursday, September 17th. The shares were sold at an average price of $75.00, for a total value of $529,650.00. Following the completion of the transaction, the chief accounting officer owned 60,804 shares in the company, valued at $4,560,300. This trade represents a 10.41% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,240,499 shares of company stock valued at $73,096,282. 24.26% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Tempus AI

Large investors have recently made changes to their positions in the company. QRG Capital Management Inc. acquired a new position in Tempus AI in the second quarter worth approximately $240,000. WINTON GROUP Ltd bought a new position in Tempus AI during the second quarter valued at approximately $342,000. Engineers Gate Manager LP acquired a new stake in Tempus AI in the second quarter valued at approximately $637,000. Integrated Wealth Concepts LLC acquired a new stake in Tempus AI in the second quarter valued at approximately $145,000. Finally, Baird Financial Group Inc. grew its position in Tempus AI by 3.4% in the second quarter. Baird Financial Group Inc. now owns 30,434 shares of the company’s stock worth $1,763,000 after acquiring an additional 994 shares in the last quarter. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI, Inc is a healthcare technology company focused on applying artificial intelligence and data analytics to precision medicine. The company combines molecular testing, clinical data and machine learning to help physicians make more informed treatment decisions and support the development of new therapies.

Tempus provides genomic and diagnostic testing services, including testing intended to identify clinically relevant mutations and other biomarkers. Its technology platform also organizes and analyzes clinical and molecular data, while its AI-enabled tools are designed to assist healthcare professionals with patient care, research and workflow management.

The company serves healthcare providers, patients, pharmaceutical companies and biotechnology researchers, primarily in the United States.